Conference Coverage

Biogen’s aducanumab stumbles on cognitive endpoints at 6 mg/kg dose

Publish date: July 23, 2015

 

FROM AAIC 2015

References

msullivan@frontlinemedcom.com

On Twitter @Alz_Gal

Pages

Recommended Reading

VIDEO: Stroop app predicts hepatic encephalopathy
MDedge Internal Medicine
Prevalence of amyloid pathology differs across dementia type and age
MDedge Internal Medicine
Hormone therapy helps mood, but not cognition, in younger menopausal women
MDedge Internal Medicine
Cognitive impairment signals subclinical vascular disease
MDedge Internal Medicine
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Internal Medicine
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Internal Medicine
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Internal Medicine
VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease
MDedge Internal Medicine
Estrogen therapy linked to brain atrophy in women with diabetes
MDedge Internal Medicine
VIDEO: Postoperative cognitive decline hits women hardest
MDedge Internal Medicine